Please wait while we open this resource.
K
Clinical reviews
INTERSTITIAL LUNG DISEASE IN 2025—PROGRESS, CHALLENGES, AND HOPE AHEAD
Department of Pulmonary Medicine, Integrated Hospital Institute, Cleveland Clinic, Cleveland, OH, USA
PDF20252 pages130 KB
Interstitial lung disease (ILD) remains a significant challenge in respiratory medicine, with high mortality rates and a substantial burden on patients and healthcare systems. Despite advancements in diagnostics and treatment over the past decade, ILD continues to be a progressive disorder for many. The editorial emphasizes the heterogeneity of ILD and the importance of individualized management strategies based on disease phenotyping. It also outlines the evolving understanding of ILD, including new guidelines and emerging therapeutic options that may improve patient outcomes.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
CHALLENGES OF SARCOIDOSIS AND ITS MANAGEMENT
Same clinical topic · Pulmonology
THE NEW ERA OF ADD-ON ASTHMA TREATMENTS: WHERE DO WE STAND?
Same clinical topic · Pulmonology
PLEURAL EFFUSION IN CRITICALLY ILL PATIENTS AND INTENSIVE CARE SETTING
Same clinical topic · Pulmonology
OBESITY AND ACUTE PULMONARY EMBOLISM
Same clinical topic · Pulmonology
Management of Life-Threatening Asthma
Same clinical topic · Pulmonology
Management of Life-Threatening Asthma
Same clinical topic · Pulmonology
INTERSTITIAL LUNG DISEASES
Same clinical topic · Pulmonology
DIAGNOSTIC ACCURACY OF CHEST X-RAY SCREENING FOR SILICOSIS: A SYSTEMATIC REVIEW, META-ANALYSIS AND MODELLING STUDY
Same clinical topic · Pulmonology
Definitions of non-response and response to biological therapy for severe asthma: a systematic review
Same clinical topic · Pulmonology